Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinolines for the treatment of PI3K-δ mediated diseases

Quinolines for the treatment of PI3K-δ mediated diseases

US Patent 8329910 · Granted Dec 11, 2012

Estimated economic value: $82,194,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted piperazines as KRAS G12C inhibitors2024
KRAS G12C inhibitors and methods of using the same2024
KRAS G12C inhibitors and methods of using the same2023
Substituted imidazo[4,5-c][1,8]naphthyridines as phosphodiesterase inhibitors2023
Phosphatidylinositol 3-kinase inhibitors2023
Compounds useful to treat influenza virus infections2022
Quinoline analogs as phosphatidylinositol 3-kinase inhibitors2022
Substituted piperazines as KRAS G12C inhibitors2022
KRAS G12C inhibitors and methods of using the same2021
KRAS G12C inhibitors and methods of using the same2021
Quinoline analogs as phosphatidylinositol 3-kinase inhibitors2020
KRAS G12C inhibitors and methods of using the same2019